The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes

被引:115
作者
Han, Shu-fang [1 ]
Liu, Peng
Zhang, Wei
Bu, Lun
Shen, Min
Li, Hu
Fan, Yan-hong
Cheng, Kang
Cheng, He-xiang
Li, Cheng-xiang
Jia, Guo-liang
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Dept Oral Histol & Pathol, Coll Stomatol, Xian 710032, Peoples R China
关键词
atherosclerosis; immunity; lymphocytes; destabilization;
D O I
10.1016/j.clim.2007.03.546
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Different subsets of T lymphocytes have different functions in atherosclerosis advancement. T helper 1 cells and T regulatory 1 cells have been demonstrated to play opposite roles in rupture of atherosclerotic lesion. However, the role of novel subset of T regulatory cells, known as CD4+CD25+Foxp3+ T cells, remains largely unknown in coronary artery disease (CAD). In this study, we investigated the peripheral CD4+CD25+Foxp3+ T cells of patients with CAD and controls. The patients submitted were divided into three groups: stable angina pectoris (SA) group, unstable angina pectoris (UA) group and acute myocardial infarction (AMI) group. We analyzed the frequencies of peripheral CD4+CD25+Foxp3+ T cells and T helper 1/T helper 2 cells, expression of Foxp3 in CD4+CD25+ T subsets and cytokines pattern in patients and controls. We found that the reduction of CD4+CD25+Foxp3+ T lymphocytes was consistent with the expansion of Th1 cells in patients with unstable CAD. The reversed development between CD4+CD25+ Tregs and Th1 cells might contribute to plaque destabilization. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 33 条
[1]   Natural regulatory T cells control the development of atherosclerosis in mice [J].
Ait-Oufella, H ;
Salomon, BL ;
Potteaux, S ;
Robertson, AKL ;
Gourdy, P ;
Zoll, J ;
Merval, R ;
Esposito, B ;
Cohen, JL ;
Fisson, S ;
Flavell, RA ;
Hansson, GK ;
Klatzmann, D ;
Tedgui, A ;
Mallat, Z .
NATURE MEDICINE, 2006, 12 (02) :178-180
[2]   Innate and acquired immunity in atherogenesis [J].
Binder, CJ ;
Chang, MK ;
Shaw, PX ;
Miller, YI ;
Hartvigsen, K ;
Dewan, A ;
Witztum, JL .
NATURE MEDICINE, 2002, 8 (11) :1218-1226
[3]   Reduced immunoregulatory CD31+ T cells in the blood of atherosclerotic mice with plaque thrombosis [J].
Caligiuri, G ;
Groyer, E ;
Khallou-Laschet, J ;
Zen, AAH ;
Sainz, J ;
Urbain, D ;
Gaston, AT ;
Lemitre, M ;
Nicoletti, A ;
Lafont, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) :1659-1664
[4]   Quantification of regulatory T cells in patients with systemic lupus erythematosus [J].
Crispin, JC ;
Martínez, A ;
Alcocer-Varela, J .
JOURNAL OF AUTOIMMUNITY, 2003, 21 (03) :273-276
[5]   T lymphocytes in atherosclerosis - The yin-yang of Th1 and Th2 influence on lesion formation [J].
Daugherty, A ;
Rateri, DL .
CIRCULATION RESEARCH, 2002, 90 (10) :1039-1040
[6]   Cutting edge:: CD4+CD25+ for intestinal homing can regulatory T cells impaired prevent colitis [J].
Denning, TL ;
Kim, G ;
Kronenberg, M .
JOURNAL OF IMMUNOLOGY, 2005, 174 (12) :7487-7491
[7]   Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy [J].
Ehrenstein, MR ;
Evans, JG ;
Singh, A ;
Moore, S ;
Warnes, G ;
Isenberg, DA ;
Mauri, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (03) :277-285
[8]   Deleting TCRαβ+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice [J].
Elhage, R ;
Gourdy, P ;
Brouchet, L ;
Jawien, J ;
Fouque, MJ ;
Fiévet, C ;
Huc, X ;
Barreira, Y ;
Couloumiers, JC ;
Arnal, JF ;
Bayard, F .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (06) :2013-2018
[9]   Immune function in atherogenesis [J].
Getz, GS .
JOURNAL OF LIPID RESEARCH, 2005, 46 (01) :1-10
[10]   Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease [J].
Hansson, GK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16) :1685-1695